Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
Case histories of three Rhodesian sleeping sickness patients who relapsed after Mel-B therapy are presented. Repeated Mel-B therapy was clinically effective but not curative, and all three patients subsequently relapsed again and required further treatment.
Bales
J D
JD
Walter Reed Project, Kenya Medical Research Institute, Nairobi.
Harrison
S M
SM
Mbwabi
D L
DL
Schecter
P J
PJ
D000328:Adult; D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007630:Kenya; D008297:Male; D008549:Melarsoprol / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D013498:Suramin / Q000627:therapeutic use; D014346:Trypanosoma brucei brucei; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D001152:Arsenicals; D013498:Suramin; D008549:Melarsoprol; D000518:Eflornithine